# Escalier Biosciences B.V. — Form D

Escalier Biosciences B.V. of NIJMEGEN, P7, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-20. The offering totals $15.5M, of which $3.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-03-20
- Form: D
- Accession: 0001701386-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.5M
- Amount sold: $3.5M
- Remaining: $12.0M
- Investors: 5
- Date of first sale: 2017-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-282926

## Issuer

- Name: Escalier Biosciences B.V.
- CIK: 0001701386
- Entity type: Corporation
- Jurisdiction: NETHERLANDS
- Incorporated: 2016
- Address: TRANSISTORWEG 5J, NIJMEGEN, P7, 6534
- Phone: 8589452393

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Raju Mohan | Director | San Diego, CA |
| Somasundaram Subramaniam | Director | San Diego, CA |
| E.C.M. van Wezel | Director | Nijmegen, P7 |
| Christopher Krueger | Executive Officer | Nijmegen, P7 |

## More

- [CIK 1701386 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701386&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001701386-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.